Correlation Between Ideaya Biosciences and Kiniksa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Kiniksa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Kiniksa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Kiniksa Pharmaceuticals, you can compare the effects of market volatilities on Ideaya Biosciences and Kiniksa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Kiniksa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Kiniksa Pharmaceuticals.
Diversification Opportunities for Ideaya Biosciences and Kiniksa Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ideaya and Kiniksa is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Kiniksa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiniksa Pharmaceuticals and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Kiniksa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiniksa Pharmaceuticals has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Kiniksa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ideaya Biosciences and Kiniksa Pharmaceuticals
Given the investment horizon of 90 days Ideaya Biosciences is expected to under-perform the Kiniksa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ideaya Biosciences is 1.36 times less risky than Kiniksa Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Kiniksa Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,994 in Kiniksa Pharmaceuticals on November 2, 2024 and sell it today you would lose (6.00) from holding Kiniksa Pharmaceuticals or give up 0.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Ideaya Biosciences vs. Kiniksa Pharmaceuticals
Performance |
Timeline |
Ideaya Biosciences |
Kiniksa Pharmaceuticals |
Ideaya Biosciences and Kiniksa Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ideaya Biosciences and Kiniksa Pharmaceuticals
The main advantage of trading using opposite Ideaya Biosciences and Kiniksa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Kiniksa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiniksa Pharmaceuticals will offset losses from the drop in Kiniksa Pharmaceuticals' long position.Ideaya Biosciences vs. AnaptysBio | Ideaya Biosciences vs. MeiraGTx Holdings PLC | Ideaya Biosciences vs. Keros Therapeutics | Ideaya Biosciences vs. Ventyx Biosciences |
Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |